VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $951,799 | -82.3% | 85,980 | -74.0% | 0.00% | -80.0% |
Q2 2023 | $5,364,246 | -62.1% | 330,922 | -61.1% | 0.01% | -66.7% |
Q1 2023 | $14,153,416 | +58.3% | 850,055 | -10.6% | 0.02% | +50.0% |
Q4 2022 | $8,941,656 | +23430.7% | 951,240 | +6760.2% | 0.01% | – |
Q3 2022 | $38,000 | -24.0% | 13,866 | -19.8% | 0.00% | – |
Q2 2022 | $50,000 | -90.5% | 17,300 | -90.2% | 0.00% | – |
Q1 2022 | $529,000 | +445.4% | 176,278 | +983.3% | 0.00% | – |
Q2 2021 | $97,000 | -20.5% | 16,273 | -15.4% | 0.00% | – |
Q1 2021 | $122,000 | -12.2% | 19,239 | -22.3% | 0.00% | – |
Q4 2020 | $139,000 | -59.7% | 24,765 | -58.2% | 0.00% | – |
Q3 2020 | $345,000 | -35.8% | 59,257 | -20.5% | 0.00% | -100.0% |
Q2 2020 | $537,000 | +62.2% | 74,517 | +5.3% | 0.00% | 0.0% |
Q1 2020 | $331,000 | +203.7% | 70,798 | +422.8% | 0.00% | – |
Q4 2019 | $109,000 | -77.2% | 13,541 | -50.6% | 0.00% | -100.0% |
Q3 2018 | $478,000 | -50.6% | 27,426 | -73.1% | 0.00% | 0.0% |
Q2 2018 | $967,000 | – | 101,846 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |